期刊文献+

Anxiety symptoms in patients with Mayer-Rokitansky-Küster-Hauser syndrome:a cross-sectional study 被引量:7

原文传递
导出
摘要 Background:As a congenital malformation that results in infertility and an inability to have vaginal intercourse,Mayer-Rokitansky-Küster-Hauser(MRKH)syndrome places a considerable psychological burden on patients,which results in anxiety symptoms.However,only single case studies or a few small to medium-sized cross-sectional studies were identified to focus on anxiety symptoms in MRKH patients.Thus,the aim of this study was to explore the status of anxiety symptoms and the related factors in patients with MRKH syndrome.Methods:This cross-sectional study involving 141 patients with MRKH syndrome and 178 healthy women was conducted from January 2018 to December 2018.All participants were required to complete a demographic questionnaire and the Generalized Anxiety Disorder 7-item scale(GAD-7),Patient Health Questionnaire-9,Eysenck Personality Questionnaire-Revised,Short Scale for Chinese,and Chinese Version of the Female Sexual Function Index.The main outcome was the anxiety symptoms measured by the GAD-7.Main outcome was compared between the MRKH syndrome group and the healthy control group.Then,we explored the related factors by comparing patients with and without anxiety symptoms.Results:Of the respondents,24.1%experienced moderate to severe anxiety symptoms.Patients with MRKH syndrome manifested more severe anxiety symptoms than healthy women.Negative self-evaluation of femininity(odds ratio[OR]2.706,95%confidence interval[CI]1.010-7.247),neurotic personality traits(OR 1.100,95%CI 1.029-1.175),and coexisting depressive symptoms(OR 4.422,95%CI 1.498-13.049)were more prevalent in anxious patients.Conclusion:The findings stress the importance of anxiety symptom screening in MRKH patients and identify patients at risk of anxiety symptoms,providing a possible basis for future intervention.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2020年第4期388-394,共7页 中华医学杂志(英文版)
  • 相关文献

参考文献1

二级参考文献12

  • 1Olfson M,Fireman B,Weissman MM,et al.Mental disorders and disability among patients in a primary care group practice.Am J Psychiatry,1997,154:1734-1740.
  • 2Roy-Byrne PP,Wagner A.Primary care perspectives on generalized anxiety disorder.J Clin Psychiatry,2004,65(suppl13):20-26.
  • 3Leon AC,Olfson M,Broadhead WE,et al.Prevalence of mental disorders in primary care:implications for screening.Arch Fam Med,1995,4:857-861.
  • 4Arikian SR,Gorman JM.A review of the diagnosis,pharmacologic treatment,and economic aspects of anxiety disorders.Primary Care Companion J Clin Psychiatry,2001,3:110-117.
  • 5Culpepper L.Use of algorithms to treat anxiety in primary care.J Clin Psychiatry,2003,64(suppl2):30-33.
  • 6L(o)we B,Unützer J,Callahan CM,et al.Monitoring depression treatment outcomes with the Patient Health Questionnaire-9.Med Care,2004,42:1194-1201.
  • 7Spitzer RL,Kroenke K,Williams JBW,et al.A brief measure for assessing generalized anxiety disorder:the GAD-7.Arch Intern Med,2006,166:1092-1097.
  • 8DeVellis RF.Scale development:theory and applications.Newbury Park:Sage Publications,1991:18-42.
  • 9L(o)we B,Decker O,Müller S,et al.Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population.Medical Care,2008,46(3):266.
  • 10Garcia-Campayo J,Zamorano E,Ruiz M,et al.Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool.Health Qual Life Outcomes,2010,8(1):8.

共引文献440

同被引文献32

引证文献7

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部